Heart Disease Company Tenaya Therapeutics Files For $100M US IPO

  • Tenaya Therapeutics TNYA is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday.
  • The biotech firm is attacking heart disease through three different angles - gene therapy, cellular regeneration, and precision medicine. 
  • Its $106 million series C, pulled off back in March, was designed to help propel several preclinical programs toward the clinic, including gene therapy for hypertrophic cardiomyopathy (HCM) and set up a site in the Bay Area to manufacture vectors.
  • Tenaya is starting with an AAV-based gene therapy targeting mutations in the MYBPC3 gene, the leading genetic cause of HCM.
  • According to its SEC-1 filing, it plans INDs for its gene therapy and precision medicine platforms in 2022. 
  • In addition to VC backers The Column Group and Casdin Capital, Tenaya's key shareholders include Walmart heir Thomas Walton.

Posted In: BriefsGene EditingBiotechNewsHealth CareOfferingsIPOsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.